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Available online 15 September 2016Wernicke's encephalopathy is often undiagnosed, particularly in non-alcoholics. There are very few reports of
non-alcoholic patients diagnosed with Korsakoff syndrome in the absence of a prior diagnosis of Wernicke's en-
cephalopathy and no studies of diffusion tensor imaging in non-alcoholic Korsakoff syndrome. We report on
three non-alcoholic psychiatric patients (all women) with long-term non-progressive memory impairment
that developed after malnutrition accompanied by at least one of the threeWernicke's encephalopathymanifes-
tations: ocular abnormalities, ataxia or unsteadiness, and an alteredmental state ormildmemory impairment. In
neuropsychological examination, all patients had memory impairment, including intrusions. One patient had
mild cerebellar vermis atrophy in MRI taken after the second episode of Wernicke's encephalopathy. The same
patient had mild hypometabolism in the lateral cortex of the temporal lobes. Another patient had mild symmet-
rical atrophy and hypometabolism of the superior frontal lobes. Two patients were examinedwith diffusion ten-
sor imaging. Reduced fractional anisotropy values were found in the corona radiata in two patients, and the
uncinate fasciculus and the inferior longitudinal fasciculus in one patient. Our results suggest that non-alcoholic
Korsakoff syndrome is underdiagnosed. Psychiatric patients with long-term memory impairment may have
Korsakoff syndrome and, therefore, they should be evaluated for a history of previously undiagnosedWernicke's
encephalopathy.
© 2016 Elsevier B.V. All rights reserved.Keywords:
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Wernicke's encephalopathy1. Introduction
Korsakoff syndrome (KS) is characterized by chronic cognitive im-
pairment that predominantly affects memory [1]. KS is caused by thia-
mine deﬁciency that often manifests as Wernicke's encephalopathy
(WE) [2–5]. Alcohol abuse predisposes to thiamine deﬁciency; howev-
er,WE can also occur inmalnourished non-alcoholics [5]. The full classic
triad (ocular abnormalities, ataxia or unsteadiness, and an altered men-
tal state ormild memory impairment) has been shown not to be a validMedical Center, Yliopistonkatu
lakaros), tuula.ilonen@utu.ﬁ
.paju@utu.ﬁ (J. Paju),
s.ﬁ (R. Vataja).diagnostic tool, and instead, the operationalized criteria proposed by
Caine et al (any two of four signs, the classic triad and dietary deﬁcien-
cy) are used to diagnose WE [5–7].
Previously, it was thought that non-alcoholic WE very rarely causes
KS [8–10]. However, recent studies have shown that KS often follows
non-alcoholic WE [4,7,11]. Still, results of a neuropsychological exami-
nation have been reported for only ten cases [12–20]. There are no dif-
fusion tensor imaging (DTI) studies.
At least 94% of non-alcoholic WEs remain undiagnosed [5]. It is con-
ceivable that undiagnosed non-alcoholic WE is particularly prone to
cause KS, but the recent literature contains only three case reports [12,
13,19]. It has been suggested that patients with KS who have no recog-
nized history ofWEmay come to the attention of psychiatrists [1]. Here
we report on three psychiatric patients with KS likely related to undiag-
nosed non-alcoholic WE.
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All patients were identiﬁed between 2009 and 2013 by one of the
authors (GN) by screening psychiatric patients with memory impair-
ment for nutritional deﬁciency in history, prompted by the identiﬁca-
tion of Patient 1. We reviewed medical records from other settings. All
patients had undergone neurological assessment for their memory
complaints; organic etiology was excluded but KS was not considered,
and a psychiatric etiology for the memory impairment was suggested.
The reports of previous neuropsychological examinations were avail-
able but not the numerical results.
Table 1 summarizes the manifestations of WE as assessed through
history taking and a review of the medical records. All patients have
memory problems that were ﬁrst noticed during WE or soon after it.
Psychiatric diagnoses were made in standard clinical care and were
based on ICD-10 criteria. All patients have used alcohol only occasional-
ly. None had a history of head trauma associated with unconsciousness
or posttraumatic amnesia. All patients gave written permission for use
of their medical information in this publication.2.1. Patient 1
This female patient was referred at the age of 41 by the Unemploy-
ment ofﬁcials for a psychiatric evaluation and has been treated by GN
since that time.2.1.1. WE and memory impairment
The patient had hyperemesis gravidarum andWEmanifestations at
the ages of 28 and 31 (Table 1). Memory problems (including a mild
confabulation tendency) emerged during the ﬁrst pregnancy, and after
delivery a clinical neuropsychological examination showed memory
impairment. She was not depressed, and a control examination six
months later (before the second pregnancy) showed improvement.
After the second delivery, clinical neuropsychological examinations at
the ages of 36, 38, 40, 41, and 44 showedmemory and attention deﬁcits,
with intrusions noted in two examinations. MRI was normal at the age
of 29, one year after the ﬁrst delivery and before the second pregnancy.
After the second delivery, MRIs at the ages of 38, 42, 43, and 47 showed
mild cerebellar vermis atrophy. Peripheral neuropathy manifested dur-
ing theﬁrst pregnancy and is treatedwith lamotrigine and nortriptyline.2.1.2. Comorbidities
Eight years before the ﬁrst WE, the patient was diagnosed with sys-
temic lupus erythematosus (SLE), which is treated with prednisolone
(2.5–5 mg/day) and hydroxychloroquine.Table 1
Causes and manifestations of non-alcoholic Wernicke's encephalopathy in three psychiatric pa
Patient Agea
Cause of
Wernicke's
Nutritional deﬁciency Symptoms an
No. (years) encephalopathy Duration Weight loss
(kg)
Lowest
BMI
Ocular
1b 28 Hyperemesis
gravidarum
8 months N/A N/A Impaired visi
1b 30 Hyperemesis
gravidarum
8 months N/A N/A –
2 42 Vomiting, infection 2 months 10 N/A Diplopiac, exo
3 37 Diarrhea & vomiting 6 months 5c 15.6c Anisocoriac, i
photosensitiv
N/A = Not available.
a Age at the time of Wernicke's encephalopathy.
b Patient 1 had two episodes of WE.
c Information from hospital records.2.1.3. Prior psychiatric treatment
At the age of 39, eight years after the secondWE, the patient was di-
agnosed with moderate major depression at the psychiatric outpatient
clinic of Turku University Hospital. Antidepressant medication
(escitalopram 20 mg/day, citalopram 40 mg/day) was of no clear
beneﬁt.
2.1.4. Course and outcome
Before being diagnosed with SLE, the patient had excellent grades at
school. Chronic fatigue forced her to interrupt high school and she be-
came an artisan, but she has worked as a factory worker. Following
the second delivery, the patient has beenmostly on sick leave or unem-
ployed and on a part-time disability pension for the last ﬁve years. She
has been treated by GN for the last six years. Bupropion (300 mg/day),
venlafaxine (150 mg/day), and duloxetine (60 mg/day) medications
were tried, but theywere discontinued because of side-effects. Current-
ly, at the age of 48, the patient has mildmood symptoms, and she is un-
able towork even part-timedue to the continuingmemory impairment.
2.2. Patient 2
This female patient was referred to GN by her occupational health
physician for a psychiatric assessment because of moderate major de-
pression at the ages of 54 and 55.
2.2.1. WE and memory impairment
The patientwas diagnosedwith hypogammaglobulinemia at the age
of 42. She was treated with cortisone and antibiotics for pyelonephritis,
pneumonia, and severe urticaria. A CT examination showed frontal atro-
phy. There was weight loss and WE manifestations (Table 1), and she
has since had memory problems. Clinical neuropsychological examina-
tions at the ages of 50, 53, and 55 showed deﬁcits in memory (with in-
trusions), attention, visuoconstructive abilities, and executive functions.
MRIs at the ages of 43 and 55 showed mild symmetrical atrophy of the
superior frontal lobes and a small arachnoid cyst in the cerebellum. The
second MRI was a 3T examination taken at the time of PET.
2.2.2. Prior psychiatric treatment
The patient was treated for mood problems and anxiety at the ages
of 39, 41, and 43.
2.2.3. Course and outcome
Antidepressant medication (venlafaxine 150 mg/day) reduced the
psychiatric symptoms, but the memory impairment persisted. The pa-
tient has a college degree and is on a partial disability pension.tients with Korsakoff syndrome.
d signs of Wernicke's encephalopathy
Unsteadiness/ataxia Altered mental state or mild memory
impairment
onc Unsteadiness Mild confusion, memory impairment
Unsteadiness Mild confusion
phoriac, impaired visionc – Mild confusion
mpaired visionc,
ityc
Unsteadiness,
clumsinessc
Memory impairmentc
Table 2
Results of neuropsychological tests of memory function for three patients with non-
alcoholic Korsakoff syndrome.
Test Patient 1 Patient 2 Patient 3
Agea 46 55 43
Working memory
Verbal −1 0 −1.33
Visual −1 0 −0.67
Episodic memory
Immediate recall
Verbal HVLT-Rb −1.64 −1.08 −1.80
WMS-IIIc −1.67 −1.67 −0.33
Visual BVMT-Rd −1.28 −1.75 0.20
Delayed recall
Verbal HVLT-Re −3.46 −3.28 −2.02
WMS-IIIf −2.33 −2 −0.67
Visual BVMT-Rg −1.75 −2.33 0.31
Verbal recognition HVLT-Rh −1.67 −4.08 −2.48
WMS-IIIi −2 0 −0.67
Test results are z-scores from the distribution of normative values. Values ≤ −1.5 are in
bold.
a Age (years) at the neuropsychological examination.
b Hopkins Verbal Learning Test–Revised (HVLT-R), sumof theﬁrst three learning trials.
c Wechsler Memory Scale (WMS-III), logical memory I.
d Brief Visuospatial Memory Test – Revised (BVMT-R), sum of the ﬁrst three learning
trials.
e HVLT-R, delayed free recall trial (trial 4).
f WMS-III, logical memory II.
g BVMT-R, delayed free recall trial (trial 4).
h HVLT-R, recognition trial.
i WMS-III, logical memory recognition score + 24 (presumed perfect Verbal Paired
Associates recognition). According to Lezak, Howieson, Bigler, and Tranel, Neuropsycho-
logical assessment, 5th edition (2012), page 527.
Table 3
Results of neuropsychological tests other than memory for three patients with non-alco-
holic Korsakoff syndrome.
Patient 1 Patient 2 Patient 3
Agea (years) 46 55 43
General attentionb −0.25 0 −0.84
Divided attentionc 0.84 1.28 0.52
Psychomotor speedd 0 0 −1
Verbal skille −0.67 −0.67 −1
Executive functions
Planning & foresightf 0.81 −1.23 0.10
Set shiftingg 0.74 −0.28 0.33
Task switchingh 0.67 1.96 1.04
Verbal ﬂuencyi 0.20 3.09 0.31
Composite scorej 0.61 0.89 0.45
Test results are z-scores from the distribution of normative values.
a Age at the neuropsychological examination.
b Trail Making Test A.
c Trail Making Test B.
d Digit symbol subtest of the Wechsler Adult Intelligence Scale–III.
e Vocabulary subtest of the Wechsler Adult Intelligence Scale–III.
f NAB Mazes test.
g Wisconsin Card Sorting test.
h Trail Making Test B score –Trail Making Test A score.
i The categoryﬂuency test (animals) and thewordﬂuency test (words startingwith the
letter “s”).
j Average of f, g, h, and i.
298 G. Nikolakaros et al. / Journal of the Neurological Sciences 370 (2016) 296–3022.3. Patient 3
This female patient has been treated by GN since the age of 43 years,
when she had already been on treatment at an outpatient psychiatric
clinic.
2.3.1. WE and memory impairment
The patient had gastroenteritis after her second delivery at the age of
37. For thenext sixmonths, she had dailymorningnausea and vomiting,
herweight dropped, and shedeveloped typicalWE symptoms (Table 1).
MRI was normal, as well as MRIs at the ages of 42 and 44. She has had
memory problems (including a mild confabulation tendency) since
the WE episode. In her early twenties, she learned many plant names
in Finnish and Latin. In her gardening job, she has mainly used the
Latin names. After WE, she only remembers those Latin names. In addi-
tion, she remembers poorly events from a period of two years before the
WE. At the age of 38, a clinical neuropsychological examination found
impairment of attention and memory. Examinations at the ages of 42
and 43 showed some improvement. Seventeen years before the WE,
she had had diarrhea for six months and her weight dropped, but
there were no WE manifestations.
2.3.2. Prior psychiatric treatment
A fewmonths after theWE, the patientwas referred for a psychiatric
evaluation to the outpatient psychiatric clinic and was diagnosed with
neurasthenia and moderate major depression. She was treated with
citalopram 20 mg/day, which reduced anxiety but did not affect the
memory problem.
2.3.3. Course and outcome
Currently, at the age of 45, the patient uses citalopram 20 mg/day,
clonazepam 0.5 mg/day, and gabapentin 600 mg/day medications, and
she has mild mood symptoms. She has unsteadiness and intermittent
anisocoria, and the memory impairment has persisted.
3. Methods
All patients underwent a neuropsychological examination between
December 2014 and February 2015. Results at least 1.5 SDs lower than
the mean of normative values were considered abnormal. Patients 1
and 3 underwent a 3TMRI examination with DTI using a previously de-
scribed protocol [21]. We examined the corpus callosum (genu, body,
and splenium), the superior and inferior cingulum, the uncinate fascic-
ulus (UF), the superior longitudinal fasciculus, the arcuate fasciculus,
the inferior fronto-occipital fasciculus, the inferior longitudinal fascicu-
lus (ILF), the projection tracts through corona radiata, the prefrontal
projection ﬁbers, and the projection tracts through mesencephalon.
Since only the descending fornix is damaged in alcoholic WE [22], the
entire fornix and the descending fornix were examined separately. FA-
values at least 2 SDs lower than the mean of normal controls were con-
sidered abnormal. Patients 1 and 3 were examined twice, in 2010/2015
and 2013/2014, respectively, and their results remained unchanged. All
patients were examined by [18F]-ﬂuorodeoxyglucose (FDG) PET exam-
ination at the Turku University Hospital between 2012 and 2014. Pa-
tients 1 and 3 were examined twice, in 2012/2014 and 2013/2014
respectively.
4. Results
4.1. Neuropsychological examination
All patients had abnormal results in verbal immediate and delayed
recall, and verbal recognition (Table 2). Patient 1 had impaired visual
delayed recall, and patient 2 had impaired visual immediate and de-
layed recall. Visual and verbalworkingmemorywas normal. In theHop-
kins Verbal Learning Test – Revised, Patients 1 and 3 had ﬁve intrusions,and Patient 2 had no intrusions. In the logical memory test (Wechsler
Memory Scale - III), Patient 1 had 10 intrusions, patient 2 had 12 intru-
sions and Patient 3 had 16 intrusions. In the other neuropsychological
tests, including tests of executive functions, all results were normal
(Table 3).
4.2. DTI (Fig. 1)
We found abnormal FA-values in both patients examined: in the UF
(Patient 3, both sides), the ILF (Patient 1, both sides), and the corona
radiata (Patient 1 left side, Patient 3 both sides).
Fig. 1. Reduction of ﬁbers and volumes in the tractograms of the inferior longitudinal
fasciculus of patient 1 (a) and in the tractograms of the uncinate fasciculus of patient 3
(b) obtained at threshold FA 0.15 and angle 27 degrees (blue); tractograms of a normal
control obtained at the same thresholds are shown on the right as violet.
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Patient 1 hadmild hypometabolism in the lateral temporal cortex bi-
laterally in both examinations. In a clinical semiquantitative comparison
with normal controls, the left temporal area showed a radioligand up-
take of−1.9 SDs in 2012 and−1.4 SDs in 2014, and the right temporalFig. 2. [18] FDG PET andMRI images of the lateral temporal lobes of case 1 (a and b coronal slice
sagittal slices). White and red arrows show areas of hypometabolism and atrophy, respectivelyarea an uptake of−1.6 SDs in 2012 and−1.1 SDs in 2014. Patient 2 had
two normal PET examinations. Patient 3 had mild hypometabolism in
the superior frontal lobes.
5. Discussion
We have described three non-alcoholic psychiatric patients with
long-term memory difﬁculties likely related to previously undiagnosed
WE. Neuropsychological examination showed memory impairment.
DTI showed persistently decreased FA-values in two patients. PET
showed mild hypometabolism in two patients.
In all nine previously reported cases of non-alcoholic KS where de-
layed memory was tested, it was found impaired [12–19]. Immediate
memory was impaired in ﬁve of eight tested cases [13–16,20], in one
case it was reported as unaffected but test results appear to indicate im-
pairment [19], in one case impairment receded during follow-up [12],
and in one case immediate memory was normal [17]. Recognition was
impaired in all three tested cases [12,14,19]. Working memory was ex-
amined in ﬁve cases; in four cases, it was normal [13,14,19,20], whereas
in one case impairment receded during follow-up [16]. Intrusions (pro-
voked confabulations) in neuropsychological testing indicate organic
brain damage, including alcoholic KS [23–25]. In two previously report-
ed cases of non-alcoholic KS intrusions were reported [15,19], whereas
in another case there were no intrusions [14]. In alcoholic KS executive
functions are impaired [26]. Executive functions were tested in seven
previously reported cases of non-alcoholic KS; in ﬁve cases they were
impaired [12,13,15,16,19], and in one case they were intact [14]. One
study reported impairment, but test results can be interpreted as nor-
mal [20]. Neuropsychological testing of our patients showed impair-
ment conﬁned to immediate and delayed episodic memory with
intrusions. Thus, the results of memory tests in our patients strongly
support the diagnosis of KS. Normal results in testing of executive func-
tions in our patients suggest that impairment of executive functions
may be more common in alcoholic compared to non-alcoholic KS, al-
though the small number of patients in our study does not allow ﬁrm
conclusions to be made. Preservation of executive functions may help
patients partially adjust to the memory impairment and lead to under-
diagnosis of non-alcoholic KS. Remote memory impairment has been
previously documented neuropsychologically in two non-alcoholic KS
patients [13,14], whereas in one case impairment receded during fol-
low-up [12] and in another improved [17]. We did not test remotes, c and d axial slices) and of the upper frontal lobes of case 2 (e and f coronal slices, g and h
.
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ment compatible with the multiple trace theory, where rehearsal and
reactivation protect memories [27]. This patient has also retrograde au-
tobiographical memory impairment with a temporal gradient.
Patient 3 had a normal MRI during WE. The diagnostic sensitivity of
MRI in alcoholicWE is only 53% [28]. In the review by Galvin et [5], con-
ventional MRI was positive for non-alcoholicWE in 99% of the cases be-
longing to clinical series. However, a positive MRI ﬁnding was an
essential reason for diagnosis, which suggests a selection bias. In con-
trast, in a recent study of non-alcoholic WE serum thiamine was mea-
sured in most patients, and reliance on MRI for diagnosis was
probably less pronounced [7]. In this study, only three out of ten pa-
tients had WE ﬁndings in MRI.
The medical records of our patients do not mention that the diagno-
sis of WE was considered at the time of occurrence. Our results support
the need for a high index of suspicion for non-alcoholic WE in a broad
range of clinical situations, as previously stressed [2–5,7]. Repeated ep-
isodes of subclinical alcoholicWEmay cause KS [29,30]. Patients 1 and 3
had two periods of probable nutritional deﬁciency. Only in Patient 1
both episodes were accompanied by WE symptoms, and the memory
impairment improved in between. During WE, coexisting deﬁciencies
of other micronutrients might have exacerbated the deleterious effect
of thiamine deﬁciency in our patients [31].
In all ﬁve previously reported cases of neuropsychologically docu-
mented non-alcoholic KS also studied with MRI, there were no atrophy
ﬁndings [12,13,15,17,19]. However, MB atrophy [32–34], thalamic atro-
phy [35], and vermis atrophy [36] have been reported in studies that
mention memory impairment after non-alcoholic WE. In our patients,
therewas nomarked atrophy inMRI. Patient 1 hadmild cerebellar vermis
atrophy that probably emerged during or after the second WE episode.
The memory impairment improved between the two WE episodes, but
since the second episode, the impairment has persisted. Vermis atrophy
developing only after the second non-alcoholic WE episode has been
recently reported [37], but there is no information on the cognitive
outcome of this patient. Patient 3 hadmild symmetrical atrophy of the su-
perior prefrontal cortex. Frontal atrophy is common in alcoholic KS [38].
Voxel-based MRI morphometry has shown graded volume deﬁcits in
the MBs, medial thalamus, left insula, and genu of the corpus callosum
of KS and non-KS alcoholic patients in one study [39], whereas in another
study parahippocampal/hippocampal atrophy was speciﬁc to KS and
thalamic atrophy and third ventricle enlargement were more severe in
patients with KS than in cognitively normal alcoholic patients [40].
There are no previous DTI studies in non-alcoholic KS. In a previous
comparison of alcoholic KS patients and uncomplicated alcoholics, DTI
revealed damage in the corpus callosum and anterior corona radiata in
KS [41]. In another recent DTI study, the fornix was damaged in alcohol-
ic KS but also in alcoholicswithout KS [42]. Two of our patientswere ex-
amined with DTI, and reduced FA-values were found in the corona
radiata, the UF, and the ILF. Patient 3, who has clinically retrograde am-
nesia, had clearly decreased UF FA-values. It has been suggested that
disconnection between the frontal and temporal lobe (which the UF
connects) can cause retrograde amnesia [43]. UF and ILF damage is asso-
ciated with memory impairment [44–46]. More studies are needed in
order to further evaluatewhether persistentmicrostructuralwhitemat-
ter changes, as assessed by DTI, can be used a s a biomarker of non-alco-
holic KS.
In non-alcoholic KS, hypometabolismhas been shown in the thalami
and the frontal, temporal, parietal, and occipital lobes [15,16,18]. Patient
1 had mild hypometabolism in the lateral temporal cortex, an area im-
portant in anterograde semantic [47] and episodic [48] memory, and
retrograde memory [49]. Patient 3 had mild hypometabolism in the su-
perior frontal lobes.
Two of our patients had other chronic consequences of WE. Chronic
peripheral neuropathy (Patient 1) and unsteadiness (patient 3) are not
uncommon after WE [22]. Intermittent anisocoria (Patient 3) has been
described in an early report of WE [50].The diagnosis of KS can bemissed because clinicians often expect at-
rophy of themammillary bodies (MBs) inMRI and confabulations. Con-
fabulation tendency usually subsides after the early phase [1]. Given the
dearth of non-alcoholic KS reports, clinicians may rely on studies of al-
coholic KS, which predominantly have described severe cases without
psychiatric disease. However, the range of memory impairment in alco-
holic KS is wide [22], and more than half of patients with alcoholic KS
have a psychiatric diagnosis and use psychotropicmedication [51]. A di-
agnosis of non-alcoholic KS is not routinely considered in patients with
memory impairment and, as in our patients,memory complaints can be
erroneously seen as a cognitive symptom of a psychiatric disorder.
Our results support the notion that KS patients with undiagnosed
WEmay be encountered by psychiatrists [1]. We speculate that non-al-
coholic KS after undiagnosedWEmay cause development or deteriora-
tion of psychiatric symptoms. These patients face bewildering
vocational and everyday life problems caused by the memory impair-
ment. Extensive cognitive coping efforts may lead to exhaustion, dis-
tress, compromise of psychic resources, and mood symptoms. Brain
damage of intermediate severity is more probable to cause emotional
disturbance compared to mild or very severe brain damage [52].
Our study has several limitations. We did not test remote memory
and for spontaneous confabulations. PET was interpreted clinically and
to avoid false positive results we used a very low threshold FA-value
in DTI, which reduced sensitivity. Comorbidity is an important concern.
SLE in Patient 1 has had a stable course with no ﬂares. Memory impair-
ment in SLE is associated with cerebral atrophy or vascular lesions [53],
or hippocampal atrophy [54]. Mild cognitive deﬁcits can occurwith nor-
malMRI, butmemory is not disproportionally affected [55]. Therefore, it
is very unlikely that SLE has caused the memory problem. Psychiatric
disease can cause cognitive impairment. Anterograde episodic memory
may be impaired inmajor depression, but cognitive functions are usual-
ly broadly affected [56]. Intrusions in memory testing may occur in de-
pression too, but they are associated with anosognosia for the memory
deﬁcit [57]. In a study of slightly younger subjects, psychiatric patients
produced a mean of 0.47 and controls a mean of 0.18 intrusions in the
Hopkins Verbal Learning Test – Revised, the difference was not statisti-
cally signiﬁcant [58]. DTI changes have been described in mood disor-
ders, but according to a recent meta-analysis they are restricted to the
corpus callosum and the cingulum [59]. Depression is associated with
brain hypometabolism but not in the temporal lobes or the superior
frontal lobes [60]. The memory problems of Patients 1 and 3 began at
the timeofWE; psychiatric symptoms developed later. Thememory im-
pairments of Patients 2 and 3 have persisted, although psychiatric treat-
ment has been otherwise beneﬁcial. Our patients are unable to work
because of memory impairment despite appropriate psychiatric
treatment.
Our study has also strengths. The patients have been followed for up
to six years and were last assessed 7–18 years after WE. This long fol-
low-up period increases conﬁdence in the KS diagnosis. Findings from
the previous clinical neuropsychological examinations also support
the diagnosis of KS. Our neuropsychological examination and the DTI
were the same for all patients.
Our results suggest that non-alcoholic KS is underdiagnosed in psy-
chiatric patientswith a history ofmalnutrition, and expand the diagnos-
tic spectrum to the recognition of KS among psychiatric patients with
memory impairment of intermediate severity. Diagnosing somatic dis-
ease is essential in psychiatric care. Non-alcoholic KS should be consid-
ered for all patientswith chronic, non-progressivememory impairment.
Studying these patients in sufﬁcient numbers could provide a better un-
derstanding of KS and memory function.
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